ALGS short interest
Aligos Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 708,744 |
|---|---|
| Change vs prior report | 11,061 (+1.6%) |
| Change over six months | +131.5% |
| Days to cover | 14.35 (sector: 3.78) |
| Average daily volume | 49,392 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
ALGS short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 708,744 | +1.6% | 14.35 | 49,392 |
| 2026-09-15 | 697,683 | +7.6% | 15.35 | 45,449 |
| 2026-08-31 | 648,568 | +14.2% | 9.41 | 68,891 |
| 2026-08-14 | 568,056 | -6.3% | 2.71 | 209,382 |
| 2026-07-31 | 606,525 | +16.3% | 6.39 | 94,945 |
| 2026-07-15 | 521,416 | -4.0% | 1.01 | 514,195 |
| 2026-06-30 | 543,337 | -11.2% | 7.94 | 68,442 |
| 2026-06-15 | 611,712 | +6.0% | 6.13 | 99,837 |
| 2026-05-29 | 576,909 | +7.8% | 4.75 | 121,404 |
| 2026-05-15 | 535,177 | +9.3% | 3.45 | 155,219 |
| 2026-04-30 | 489,633 | +77.6% | 1.00 | 681,214 |
| 2026-04-15 | 275,689 | -10.0% | 4.55 | 60,560 |
| 2026-03-31 | 306,176 | +3.8% | 7.59 | 40,337 |
| 2026-03-13 | 294,842 | +1.7% | 6.45 | 45,736 |
| 2026-02-27 | 289,814 | +0.4% | 11.57 | 25,044 |
| 2026-02-13 | 288,715 | -1.7% | 5.37 | 53,738 |
| 2026-01-30 | 293,582 | +9.2% | 3.46 | 84,739 |
| 2026-01-15 | 268,943 | +11.7% | 3.58 | 75,108 |
| 2025-12-31 | 240,691 | -6.8% | 4.70 | 51,173 |
| 2025-12-15 | 258,242 | +14.1% | 2.91 | 88,675 |
| 2025-11-28 | 226,418 | -3.0% | 2.77 | 81,621 |
| 2025-11-14 | 233,534 | +2.8% | 2.91 | 80,364 |
| 2025-10-31 | 227,276 | -3.3% | 2.44 | 93,262 |
| 2025-10-15 | 235,005 | -13.8% | 2.42 | 97,157 |
| 2025-09-30 | 272,621 | -6.8% | 3.55 | 76,792 |
import finzdata as yf
yf.Ticker("ALGS").short_interest # every report since 2017
yf.Client().short_interest(["ALGS"], start="2018-01-01")Healthcare short interest · ALGS price history · Who owns ALGS · All short interest